Showing 221-230 of 6775 results for "".
Protect Yourself Against System Breaches and Errors
https://practicaldermatology.com/topics/practice-management/protect-yourself-against-system-breaches-and-errors/21579/New reports of cyber-terrorism highlight the importance of EHR security.Harnessing Mobile Technology in Concert with EHRs
https://practicaldermatology.com/topics/practice-management/harnessing-mobile-technology-in-concert-with-ehrs/21637/Significant developments are on the way, but already EHRs offer unique abilities via mobile and tablet technologies.Engagement: Still Key to Healthcare Marketing in the Digital Age
https://practicaldermatology.com/topics/general-topics/engagement-still-key-to-healthcare-marketing-in-the-digital-age/21671/New economic conditions call for a strategy shift in medical practice management, and new digital opportunities can play an important roleTechnology Connection: Make Your EHR Meaningful— for Your Practice
https://practicaldermatology.com/topics/general-topics/technology-connection-make-your-ehr-meaningful-for-your-practice/21822/While much of the discussion of meaningful use has focused on government incentives, it's also important that your EHR works meaningfully for you.BUSINESS ADVISOR: The Just-in-Time Model: Smart Inventory Management in Tough Economic Times
https://practicaldermatology.com/topics/general-topics/the-just-in-time-model-smart-inventory-management-in-tough-economic-times/21963/Meeting inventory challenges can help control costs and ensure consistent cash flow during economic difficulties.DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with moNIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a patiDermWireTV: International Launch of AviClear; Biological Effects of Air Pollution on Human Skin; New AAD Guidelines for Acne Care
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-international-launch-of-aviclear-biological-effects-of-air-pollution-on-human-skin-new-aad-guidelines-for-acne-care/20261/In this episode of DermWireTV, we report on the international launch of the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. An expert discusses a recent study that examines the biological effects of air pollution on human skin equivalents. For thExosome Therapy: Explained
https://practicaldermatology.com/conferences/scale-2023/exosome-therapy-explained/20200/Jane Yoo, MD, explains exactly what exosomes are and highlights some current therapeutic uses for exosome therapy including treating hair loss and reducing redness after laser skin resurfacing.Eyeing a Treatment for Syringoma
https://practicaldermatology.com/series/scientifically-speaking/eyeing-a-treatment-for-syringoma/20112/Listen as Joel L. Cohen, MD describes early evidence for the use of nano pulse stimulation to treat syringoma, a notoriously challenging target.